Table 2.
Percentage of Ki67 positive follicles in pregraft controls, 4-week grafts, and 12-week grafts
| Follicle stage | Pregraft | 4 weeks | 12 weeks |
|---|---|---|---|
| Primordial | 10.28 % | 70.83 %a | 70.59 %a |
| (11/107) | (17/24) | (12/17) | |
| Primary | 18.18 % | 50 % | 72.73 %a |
| (2/11) | (3/6) | (8/11) | |
| Secondary | – | 100 % | 100 % |
| – | (4/4) | (14/14) | |
| Antral | – | – | 100 % |
| – | – | (2/2) | |
| Total Ki67 positive follicles | 11.02 % | 70.59 %a | 81.82 %a |
| (13/118) | (24/34) | (36/44) |
Percentage of primordial, primary, secondary, and antral follicles showing Ki67 immunostaining in pregraft controls and after 4 and 12 weeks of grafting, respectively. The total number of Ki67-positive follicles as well as the total number of all analyzed follicles are given in brackets
aSignificant difference between the two observation periods compared to the pregraft control (P < 0.05)